• Pages
  • Editions
01 Cover
02 Welcome Letter / Sections
03 Section 1: Introduction
04 Introduction to USA Life Sciences Industry
05 Janssen Interview
06 Etihad Cargo Interview
07 UPS Healthcare Interview
08 The Investment Climate
09 MPM | BioImpact Capital Interview
10 Industry Insights: Promising Forecasts for Consolidation and M&As
11 The Regulatory Landscape
12 Porzio Life Sciences Interview
13 PBOA Interview
14 EY USA Interview
15 LaVoieHealthScience Interview
16 Section 2: Established and Emerging Hubs
17 Map of US-based life sciences companies interviewed
18 The East and the West
19 BioNJ Interview
20 MassBio Interview
21 Biocom California Interview
22 PABC Interview
23 Growing Life Sciences Hubs
24 JLL Interview
25 Industry Insights: From Ivory Towers to Incubators
26 Section 3: Drug Discovery and Development
27 Drug Discovery and Development
28 Sangamo Therapeutics Interview
29 PsychoGenics Interview
30 Aphios Corporation Interview
31 Industry Insights: Biotechs Fairing in 2023
32 Ymmunobio Interview
33 Section 4: Contract Manufacturing, Services and Chemicals
34 The Industry's Growing Reliance on CDMOs
35 Pfizer CentreOne Interview
36 CordenPharma International Interview
37 AMPAC Fine Chemicals Interview
38 Adare Pharma Solutions Interview
39 Aenova Group Interview
40 Dipharma Francis Interview
41 Kindeva Drug Delivery Interview
42 Prince Sterilization Services Interview
43 Interbiome Interview
44 Adopting a Proactive Stance
45 Lonza Interview
46 Aragen Life Sciences Interview
47 Industry Insights: Contractors, Manufacturers, and Lab Services
48 Nivagen Pharmaceuticals Interview
49 Chemicals and Service Providers
50 Evonik Health Care Interview
51 Section 5: New Technologies
52 Leveraging AI for Drug Discovery
53 Apprentice.io Interview
54 Technology for Patient Centricity
55 Illumina Interview
56 Section 6: Company Profiles
57 Porzio Life Sciences Company Profile
58 Adare Pharma Solutions Company Profile
59 SK pharmteco Company Profile
60 Article & Interview Directory
61 Credits

COMPANY PROFILE


Compliance Solutions Built from the Law

Strategic Quote


“Looking ahead, my main objective is organic and inorganic growth. I want to find the next Porzio Life Sciences that was like us: had good people, good processes, and needed that financial heft to compete globally. As we build that bridge between life sciences and healthcare and build that global ecosystem, I want to put the pieces together. This is a five-year plan, and within five years, we will have a global company that provides compliance services worldwide. It is all boosted by the desire to help patients and the desire to innovate.”

John Patrick Oroho, President & General Manager, RLDatix Life Sciences, Porzio Life Sciences

Summary


Porzio Life Sciences, an RLDatix Company, is the leading provider of compliance solutions to the life sciences industry, with more than 600 customers including pharmaceutical, biotech, and medical device companies.

At Porzio Life Sciences, our services and solutions simplify compliance for life sciences companies and make it easier for companies to comply with state, federal, and global regulations governing marketing and sales in the life sciences industry. All of our compliance technology products and services are informed by our team members’ knowledge as lawyers and compliance professionals in the life sciences industry and are built from the law.

Porzio Life Sciences is a part of the RLDatix portfolio, which consists of 1,400 team members and offices across 9 countries. We focus exclusively on compliance services and software solutions for companies in the life sciences industry.

Key Leadership


John Patrick Oroho, President & General Manager, RLDatix Life Sciences, Porzio Life Sciences

John Patrick Oroho, President & General Manager of Porzio Life Sciences and RLDatix Life Sciences, meets regularly with companies to identify sales and marketing issues and to propose solutions that streamline their practices in meeting compliance requirements of all 50 states and the District of Columbia.

Mr. Oroho formerly served as principal of the law firm Porzio, Bromberg & Newman P.C., and currently is of counsel practicing in the Life Sciences Compliance and Regulatory Counseling Department. He concentrates his law practice on regulatory compliance with respect to the Prescription Drug Marketing Act (PDMA), Anti­kickback statute, False Claim Act, and Medicare and Medicaid fraud and abuse.

Previously, he served as Senior Vice President and General Counsel for the PDMA Alliance, a national trade association focused on sample distribution and pharmaceutical marketing and sales compliance. Mr. Oroho has an extensive pharmaceutical regulatory and compliance background. He spent three years as General Counsel for the company now known as QPharma, Inc.

Mr. Oroho received a J.D. from the University of Notre Dame School of Law in 1985 and a B.S. from the United States Merchant Marine Academy, where he graduated with honors in 1978.

Primary Products & Services


Our product suite offers comprehensive global compliance solutions to life sciences companies, helping them with compliance research, spend transparency reporting, and high-risk engagements in jurisdictions around the country and the world—all with world-class support from dedicated regulatory experts.

o Porzio Compliance Digest

  • The go-to source for compliance professionals looking for regulatory analysis of global, federal, and state life sciences laws relating to the marketing and sale of pharmaceuticals and medical devices.
  • Updated daily
  • Ten databases, covering all aspects of regulatory compliance

o Porzio Third Party Engagement

  • Easy-to-implement, highly configurable platform for managing any type of activity with HCP and other high-risk parties—speaker events, advisory boards, virtual conferences, and more.
  • Integrated regulatory guidance from Porzio Compliance Digest
  • Quick global deployment across business functions with flexible & configurable workflows

o Porzio Global Spend Transparency

  • The industry-leading global spend transparency reporting solution
  • “Built from the law,” ensuring reports are compliant with current regulations in more than 40 jurisdictions around the world
  • A true global transparency solution that aggregates data across jurisdictions and business units

o Porzio Price Transparency Reporting

  • Provides life sciences companies with everything needed to manage all aspects of state reporting requirements for drug pricing
  • Manage, model, and receive alerts on required drug price reporting in one end-to-end solution

o Porzio Monitoring & Analytics

  • Identify the root causes of non-compliance by leveraging predictive monitoring
  • Highlights critical data points to help you spot high-risk areas
  • Best-in-class integrations with products across the Porzio Life Sciences Compliance Risk Management Platform

Contact

LinkedIn

Twitter

Facebook

Website Email

Tel: 973-538-1690

Next:

Company Profile: Adare Pharma Solutions